Jump to content

Cancer Research, Drug Manufacturers and NICE


Recommended Posts

I suppose that if it's true, then maybe the drugs companies need to review their busines model. None in eight looks like a poor return on their investment.

Not all that much, there are plenty of other countries to sell to, and the private market in the UK

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.